Beyfortus 100 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FWFZ7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,573
Award facts
- Contract value 100% obligated
- $50,572.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $50,572.91 to AmerisourceBergen Drug Corp for Beyfortus 100 mg/ml syringes on September 22, 2025, with completion targeted for September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Beyfortus (nirsevimab) is a monoclonal antibody used for respiratory syncytial virus (RSV) prevention in infants and young children, representing a critical pharmaceutical supply for military healthcare systems and federal medical procurement.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications and medical commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains a significant portfolio of federal medical supply contracts and demonstrates consistent capability to meet competitive federal procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FWFZ7?
SPE2DB25FWFZ7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FWFZ7 worth?
The government has obligated $50,573 on SPE2DB25FWFZ7.
Is contract SPE2DB25FWFZ7 an order under another contract?
Yes. SPE2DB25FWFZ7 is a delivery order under SPE2DB24D1034, an indefinite delivery contract.
Was contract SPE2DB25FWFZ7 competed?
The extent of competition for SPE2DB25FWFZ7 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award